在内血管神经干预程序中的抗血小板剂
Kelley Flesher1, Sophia Pathan1,2, William Andrew Kofke1
1Department of Neurology, Neurocritical Care Division, University of Pennsylvania, Philadelphia, PA.
Journal of neurosurgical anesthesiology
|January 30, 2025
概括
周围程序性抗血小板剂可以改善神经干预手术的结果. 需要标准化治疗方案和监测,以优化接受这些微创治疗的患者的安全性和疗效.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 干预性放射学 干预性放射学
背景情况:
- 最少侵入性,图像引导的内血管程序,特别是神经干预,越来越常见.
- 这些手术带有内皮损伤的风险,导致血栓栓塞并发症.
- 管理抗血小板治疗是至关重要的,因为血栓栓塞和出血并发症的双重风险.
研究的目的:
- 审查抗血小板剂在神经干预手术中的作用机制,临床指示和管理.
- 突出目前临床实践的变化和标准化的需要.
主要方法:
- 对现有文献和关于神经干预中抗血小板治疗的临床共识进行了集中审查.
- 讨论抗血小板剂机制及其在周围程序环境中的应用.
主要成果:
- 临床共识支持使用周围手术抗血小板剂,以改善患者的治疗结果.
- 目前使用抗血小板剂的做法在各机构和从业人员之间存在很大差异.
结论:
- 抗血小板剂对于接受内血管神经干预的患者的管理至关重要.
- 需要进一步的研究,以建立标准化,程序特定的抗血小板疗法和监测协议.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
462
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
462
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
602
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
602